Cargando…

The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid

Systemic sclerosis (SSc) is a connective tissue disorder characterized by tissue hypoxia, excessive fibrosis of skin and internal organs, and angiogenesis imbalance. The aim of the study was to evaluate in SSc patients the association between the retinal microcirculation disturbances and the presenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waszczykowska, Arleta, Goś, Roman, Waszczykowska, Elżbieta, Dziankowska-Bartkowiak, Bożena, Podgórski, Michał, Jurowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204106/ https://www.ncbi.nlm.nih.gov/pubmed/32410862 http://dx.doi.org/10.1155/2020/7649480

Ejemplares similares

Assessment of skin microcirculation by laser Doppler flowmetry in systemic sclerosis patients
por: Waszczykowska, Arleta, et al.
Publicado: (2014)

Prevalence of ocular manifestations in systemic sclerosis patients
por: Waszczykowska, Arleta, et al.
Publicado: (2013)

Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report
por: Waszczykowska, Arleta, et al.
Publicado: (2020)

Role and effectiveness of complex and supervised rehabilitation on overall and hand function in systemic sclerosis patients—one-year follow-up study
por: Waszczykowski, Michał, et al.
Publicado: (2021)

Two-Year Accelerated Corneal Cross-Linking Outcome in Patients with Progressive Keratoconus
por: Waszczykowska, Arleta, et al.
Publicado: (2015)

Angiogenin and SDF-1α serum concentration in patients with systemic sclerosis in relation to clinical status
por: Dziankowska-Bartkowiak, Bożena, et al.
Publicado: (2011)

Conjunctival Ultraviolet Autofluorescence as a Measure of Riboflavin and Ultraviolet and Accelerated Cross-Linking Exposure in Keratoconic Patients
por: Waszczykowska, Arleta, et al.
Publicado: (2020)

Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement.
por: Dziankowska-Bartkowiak, Bozena, et al.
Publicado: (2003)

Correlation of Endostatin and Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Serum Levels With Cardiovascular Involvement in Systemic Sclerosis Patients
por: Dziankowska-Bartkowiak, Bożena, et al.
Publicado: (2005)

Abnormalities of heart rate turbulence and heart rate variability as indicators of increased cardiovascular risk in patients with systemic sclerosis
por: Poliwczak, Adam R., et al.
Publicado: (2019)

Clinical Application and Efficacy of Silver Drug in Ophthalmology: A Literature Review and New Formulation of EYE Drops with Drug Silver (I) Complex of Metronidazole with Improved Dosage Form
por: Waszczykowska, Arleta, et al.
Publicado: (2021)

Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients
por: Zarychta, Elżbieta, et al.
Publicado: (2023)

PKPD Modeling of VEGF, sVEGFR-2, sVEGFR-3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GIST
por: Hansson, E K, et al.
Publicado: (2013)

Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis
por: Debrah, Alexander Yaw, et al.
Publicado: (2006)

Retinal thickness as a marker of disease progression in longitudinal observation of patients with Wolfram syndrome
por: Zmyslowska, Agnieszka, et al.
Publicado: (2017)

Multiple Retinal Anomalies in Wfs1-Deficient Mice
por: Waszczykowska, Arleta, et al.
Publicado: (2020)

Evaluation of the effects of different treatment modalities on angiogenesis in heart failure patients with reduced/mid-range ejection fraction via VEGF and sVEGFR-1
por: Erturk, Ismail, et al.
Publicado: (2018)

Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy
por: Jürgensmeier, J M, et al.
Publicado: (2013)

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice
por: Kujala, Anni, et al.
Publicado: (2022)

Behçet's disease leaves the silk road
por: Woźniacka, Anna, et al.
Publicado: (2014)

Gene polymorphisms and serum levels of sVEGFR-1 in patients with systemic lupus erythematosus
por: Yuan, Zhi-Chao, et al.
Publicado: (2020)

sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?
por: Spearman, Andrew D., et al.
Publicado: (2021)

The HD-OCT Study May Be Useful in Searching for Markers of Preclinical Stage of Diabetic Retinopathy in Patients with Type 1 Diabetes
por: Kołodziej, Magdalena, et al.
Publicado: (2019)

Circulating angiostatin serum level in patients with systemic sclerosis
por: Gerlicz-Kowalczuk, Zofia, et al.
Publicado: (2017)

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use
por: Wu, Florence T H, et al.
Publicado: (2010)

Commentary: sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?
por: Putotto, Carolina, et al.
Publicado: (2021)

Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
por: Şalk, Sultan, et al.
Publicado: (2022)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Response to the Letter to the Editor: “Corneal thickness, optic nerve sheath diameter and retinal nerve fiber layer evaluation to assess the risk of cerebral edema in type 1 diabetes in children”
por: Jeziorny, Krzysztof, et al.
Publicado: (2019)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

Regulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells
por: Gruemmer, Ruth, et al.
Publicado: (2005)

DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma
por: Abou Faycal, Cherine, et al.
Publicado: (2018)

Lupus erythematosus panniculitis resistant to standard treatment, complicated with macrophage activation syndrome
por: Juczynska, Katarzyna, et al.
Publicado: (2017)

Searching for Effective Methods of Diagnosing Nervous System Lesions in Patients with Alström and Bardet–Biedl Syndromes
por: Waszczykowska, Arleta, et al.
Publicado: (2023)

Disturbances of circadian profile and blood pressure control in patients with systemic lupus erythematosus without overt heart disease
por: Poliwczak, Adam R., et al.
Publicado: (2022)

Serum microRNA as indicators of Wolfram syndrome’s progression in neuroimaging studies
por: Zmyslowska, Agnieszka, et al.
Publicado: (2020)

Geraniol Suppresses Angiogenesis by Downregulating Vascular Endothelial Growth Factor (VEGF)/VEGFR-2 Signaling
por: Wittig, Christine, et al.
Publicado: (2015)

Sinensetin suppresses angiogenesis in liver cancer by targeting the VEGF/VEGFR2/AKT signaling pathway
por: Li, Xiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_220cphfm4tdn8seu20g0mfqt70